Clinical Trials Logo

Clinical Trial Summary

The main aim of this study is to develop technology-based interventions to improve HIV pre-exposure prophylaxis (PrEP) uptake and adherence among Thai young transgender women.


Clinical Trial Description

Motivational Enhancement System for Adherence (MESA) is a computer-based motivation invention, based on the Information-Motivation-Behavioral Skills (IMB) model and Motivational Interviewing (MI) principles, used to promote adherence among HIV-positive youth initiating antiretroviral treatment. In this study, the team will adapt and develop MESA to focus on PrEP uptake and adherence, which will be called Motivational Enhancement System for PrEP Uptake and Adherence (MES-PrEP). YaCool is a mobile application developed to support transgender women self-management of gender and sexual health, including PrEP use. In Aim 1, the investigators will begin with needs assessment to evaluate intervention efficacy by exploring the barriers and facilitators of PrEP uptake and adherence through in-depth interviews with transgender women and community health workers. The two interventions will be developed and refined based upon the inputs from transgender women through focus group discussion and community advisory board. In Aim 2, the investigators will conduct a Multiphase Optimization Strategy (MOST) design-based trial to evaluate the feasibility, acceptability, and preliminary efficacy of MES-PrEP and Enhanced YaCool and to determine whether MES-PrEP works better when combined with Enhanced YaCool to improve PrEP use. Eligible transgender women will be randomized to one of the four experimental conditions, and followed for 12 months with assessments at baseline, month 1, 3, 6, 9 and 12. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05262426
Study type Interventional
Source University of Massachusetts, Worcester
Contact Deogwoon Kim
Phone 8576009425
Email deogwoon.kim13@umassmed.edu
Status Recruiting
Phase N/A
Start date December 27, 2021
Completion date December 31, 2025

See also
  Status Clinical Trial Phase
Recruiting NCT06162897 - Case Management Dyad N/A
Active, not recruiting NCT04064567 - Linking High-Risk Jail Detainees to HIV Pre-Exposure Prophylaxis: PrEP-LINK N/A
Completed NCT03805451 - Life Steps for PrEP for Youth N/A
Not yet recruiting NCT06046079 - Predictors of Health Service Utilizations Among Key Population in Washington DC
Recruiting NCT05929521 - Centering Those Engaged in Transactional Sex: A PrEP Innovation for Getting To Zero Early Phase 1
Not yet recruiting NCT06408142 - Universal Test and Connect for HIV Service Delivery in South Africa
Recruiting NCT05165745 - Stick2PrEP Cisgender Women and Trans Individuals N/A
Completed NCT03177512 - LYNX: A Novel Mobile App to Support Linkage to HIV/STI Testing PrEP for Young Men Who Have Sex With Men N/A
Completed NCT04205487 - PrEP Readiness Interventions for Supporting Motivation N/A
Completed NCT03965221 - Comparison of Men's Prevention Apps to Research Efficacy N/A
Completed NCT05417620 - Le Kip Kip: A Campaign to Change Social Norms and Build Sustainable Demand for PrEP Among Women in South Africa N/A
Completed NCT03226873 - Peer Outreach and Navigation Intervention to Increase PrEP Uptake Among Women at High Risk for HIV N/A
Completed NCT03493555 - Optimizing PrEP Adherence for Young Men Who Have Sex With Men N/A
Recruiting NCT05728034 - Information Seeking About Pre-exposure Prophylaxis N/A
Completed NCT03995862 - Evaluation of Pre-Exposure Prophylaxis Against HIV in Alpine Region
Completed NCT03729570 - Electronic Pre-exposure Prophylaxis (PrEP) Initiation and Maintenance Home Care System N/A
Completed NCT04248790 - Design and Development of a Mobile App to Improve Adherence to Pre-exposure Prophylaxis in Men Who Have Sex With Men N/A
Recruiting NCT05614492 - Development and Evaluation of a PrEP Decision Aid for Women Seeking Domestic Violence Services in Baltimore Phase 2/Phase 3
Completed NCT04712994 - PrEPARE: PrEP in Pregnancy, Accelerating Reach and Efficiency N/A
Completed NCT04664998 - Alignment of PrEP Use With HIV Risk in Young Women and Men Phase 4